Grants.govForecastedALN 93.853RFA-NS-28-009
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
National Institutes of Health
Amount not specifiedNo deadline
Geography
US
Award range
Amount not specified
Cost share
Not specified
Open date
Sep 23, 2026
Close date
—
Opportunity type
Discretionary
Source
Grants.gov